Telix Pharmaceuticals Limited Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Telix Pharmaceuticals Limited (TLPPF) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -$306.93 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2026-02-20
AUD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2024-12-31 | 546.78M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 8.58M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 93.99M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2025-12-31 | -$306.93M 20-F · filed 2026-02-20 |
| 2024-12-31 | $357.59M 20-F · filed 2026-02-20 |
| 2023-12-31 | $4.53M 20-F · filed 2026-02-20 |